Max Healthcare Institute Share Price

  • 874.307.75 (0.90%)
  • Volume: 7,05,123
  • Live
  • Last Updated On: 30 Aug, 2024, 02:03 PM IST
Loading...

Max Healthcare Institut...

  • 874.307.75 (0.90%)
  • Volume: 7,05,123
Advertisment

Max Healthcare share price insights

View All
  • In the last 4 years, only 3.5 % trading sessions saw intraday gains higher than 5 % .

  • Company delivered ROE of 12.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 8.87%. (Source: Consolidated Financials)

  • Company has spent 1.11% of its operating revenues towards interest expenses and 17.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • 5 day moving crossover appeared on Aug 28, 2024. Average price gain of 4.35% within 7 days of this signal in last 5 years.

  • Max Healthcare Institute Ltd. share price moved up by 0.59% from its previous close of Rs 866.55. Max Healthcare Institute Ltd. stock last traded price is 871.60

    Share PriceValue
    Today/Current/Last871.60
    Previous Day866.55865.75

InsightsMax Healthcare

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    80.35
    EPS - TTM
    (₹)
    10.84
    MCap
    (₹ Cr.)
    84,750.76
    Sectoral MCap Rank
    2
    PB Ratio
    (x)
    10.02
    Div Yield
    (%)
    0.17
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    865.69
    52W H/L
    (₹)
    979.90 / 531.05

    Max Healthcare Share Price Returns

    1 Day0.9%
    1 Week2.5%
    1 Month-4.77%
    3 Months11.99%
    1 Year51.96%
    3 Years142.19%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Max Healthcare belongs to analysts' top-rated companies list?

    View Stock Screeners

    Max Healthcare Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Max Healthcare Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 16 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy

    That's all for Max Healthcare recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy5566
    Buy4456
    Hold3332
    Sell4432
    Strong Sell----
    # Analysts16161716

    Max Healthcare Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.11% of its operating revenues towards interest expenses and 17.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income1,577.631,468.151,380.991,408.641,326.31
      Total Income Growth (%)7.466.31-1.966.215.70
      Total Expenses1,232.441,111.691,010.071,033.691,003.43
      Total Expenses Growth (%)10.8610.06-2.293.027.37
      EBIT345.19356.46370.92374.95322.88
      EBIT Growth (%)-3.16-3.90-1.0716.130.83
      Profit after Tax (PAT)236.27251.54289.34276.68240.08
      PAT Growth (%)-6.07-13.064.5815.24-4.32
      EBIT Margin (%)21.8824.2826.8626.6224.34
      Net Profit Margin (%)14.9817.1320.9519.6418.10
      Basic EPS (₹)2.432.592.982.852.47
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income664.26747.88633.43644.91586.36
      Total Income Growth (%)-11.1818.07-1.789.997.01
      Total Expenses453.46442.52420.10421.66411.68
      Total Expenses Growth (%)2.475.34-0.372.427.36
      EBIT210.80305.36213.33223.25174.68
      EBIT Growth (%)-30.9743.14-4.4427.816.19
      Profit after Tax (PAT)154.14241.77158.12161.31126.06
      PAT Growth (%)-36.2552.90-1.9827.96-0.25
      EBIT Margin (%)31.7340.8333.6834.6229.79
      Net Profit Margin (%)23.2032.3324.9625.0121.50
      Basic EPS (₹)1.592.491.631.661.30
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue5,584.094,701.844,058.822,619.41
      Total Revenue Growth (%)18.7615.8454.95136.60
      Total Expenses4,218.773,638.123,310.892,454.36
      Total Expenses Growth (%)15.969.8834.90124.28
      Profit after Tax (PAT)1,057.641,103.51605.05-137.55
      PAT Growth (%)-4.1682.38--333.18
      Operating Profit Margin (%)26.3625.1521.5813.75
      Net Profit Margin (%)19.5624.1815.38-5.49
      Basic EPS (₹)10.8911.386.25-1.59
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue2,612.582,048.831,854.461,137.29125.47
      Total Revenue Growth (%)27.5210.4863.06806.42-88.11
      Total Expenses1,747.621,485.691,451.471,073.08128.57
      Total Expenses Growth (%)17.632.3635.26734.63-87.97
      Profit after Tax (PAT)687.26694.31331.13-164.45-2.96
      PAT Growth (%)-1.02109.68---
      Operating Profit Margin (%)39.1432.2925.8517.1396.00
      Net Profit Margin (%)29.3536.4519.15-15.95-4.99
      Basic EPS (₹)7.077.163.42-1.91-0.05

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets11,999.9410,101.859,189.138,544.44
      Total Assets Growth (%)18.799.937.55115.03
      Total Liabilities3,591.802,692.262,906.662,905.76
      Total Liabilities Growth (%)33.41-7.380.03104.56
      Total Equity8,408.147,409.596,282.475,638.68
      Total Equity Growth (%)13.4817.9411.42120.85
      Current Ratio (x)1.371.861.321.45
      Total Debt to Equity (x)0.150.080.120.16
      Contingent Liabilities0.00326.66515.17388.01
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets9,068.878,420.337,502.047,142.953,552.81
      Total Assets Growth (%)7.7012.245.03101.0582.06
      Total Liabilities1,388.111,378.221,193.021,203.52677.73
      Total Liabilities Growth (%)0.7215.52-0.8777.581.96
      Total Equity7,680.767,042.116,309.025,939.432,875.08
      Total Equity Growth (%)9.0711.626.22106.58123.45
      Current Ratio (x)2.013.262.363.504.15
      Total Debt to Equity (x)0.060.060.050.060.23
      Contingent Liabilities0.00536.28828.08861.1262.04

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 1285.45 cr for investing activities which is an YoY increase of 8.29%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities1,121.801,209.18748.49117.86
      Net Cash used in Investing Activities-1,285.45-1,187.01-771.77-73.00
      Net Cash flow from Financing Activities-263.74-288.56-294.17191.33
      Net Cash Flow-429.21-266.39-317.45515.58
      Closing Cash & Cash Equivalent979.8442.75309.14626.59
      Closing Cash & Cash Equivalent Growth (%)2,192.02-86.17-50.66464.44
      Total Debt/ CFO (x)1.160.470.977.61
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities613.09696.47424.57219.24-36.12
      Net Cash used in Investing Activities-805.64-842.85-733.03-344.65-2,536.25
      Net Cash flow from Financing Activities-245.91-54.47-75.33396.682,332.24
      Net Cash Flow-438.46-200.85-383.79532.01-240.13
      Closing Cash & Cash Equivalent719.2313.15213.98597.7765.76
      Closing Cash & Cash Equivalent Growth (%)5,369.43-93.85-64.20809.021,635.09
      Total Debt/ CFO (x)0.720.650.711.51-18.21

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 12.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 8.87%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)12.5714.899.63-2.43
      Return on Capital Employed (%)13.2512.6710.064.43
      Return on Assets (%)8.8110.926.58-1.60
      Interest Coverage Ratio (x)27.8916.4510.611.92
      Asset Turnover Ratio (x)0.490.220.2229.31
      Price to Earnings (x)75.7638.9155.87-144.93
      Price to Book (x)9.485.785.353.53
      EV/EBITDA (x)47.8630.3831.6538.85
      EBITDA Margin (%)30.8930.2427.2120.70
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)8.949.855.24-2.76-0.10
      Return on Capital Employed (%)10.717.706.202.571.97
      Return on Assets (%)7.578.244.41-2.30-0.08
      Interest Coverage Ratio (x)20.0014.0312.391.570.95
      Asset Turnover Ratio (x)0.270.240.2414.431.66
      Price to Earnings (x)116.2861.73102.04-121.95-
      Price to Book (x)10.386.085.333.35-
      EV/EBITDA (x)76.9057.7261.4573.38-
      EBITDA Margin (%)44.1338.2331.5825.94101.65

    Financial InsightsMax Healthcare

    • Income (P&L)
    • Cash Flow
    • Ratios
      • Employee & Interest Expense

        Company has spent 1.11% of its operating revenues towards interest expenses and 17.28% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 1285.45 cr for investing activities which is an YoY increase of 8.29%. (Source: Consolidated Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 12.57% in year ending Mar 31, 2024 outperforming its 5 year avg. of 8.87%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Max Healthcare Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Max Healthcare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Max Healthcare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Max Healthcare

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Max Healthcare Peer Comparison

    • Max Healthcare Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty 100

        Stock gave a 3 year return of 158.59% as compared to Nifty 100 which gave a return of 54.68%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 158.59% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty 100

        Stock gave a 3 year return of 158.59% as compared to Nifty 100 which gave a return of 54.68%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 158.59% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Max Healthcare80.2810.0612.5713.258.8128.3826.3619.5610.891.370.151.16
      Apollo Hospital96.1113.6212.9514.975.3621.579.494.8162.501.130.461.65
      Fortis Healthcare64.484.927.819.524.5019.1413.979.227.930.450.110.78
      Global Health62.8010.4316.4519.0111.1130.9921.4014.5917.802.440.140.69
      Narayana Hruday32.539.0927.3621.8214.0324.6819.6315.7338.861.750.501.35
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Aster DM Health
      • Krishna Instt of Medical Sciences
      • Rainbow Childrens
      • Jupiter Life Line Hospitals
      • Healthcare Global

      Choose from Stocks

      Peers InsightsMax Healthcare

      • Stock Returns vs Nifty 100

        Stock gave a 3 year return of 158.59% as compared to Nifty 100 which gave a return of 54.68%. (as of last trading session)

      • Stock Returns vs BSE Healthcare

        Stock generated 158.59% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Max Healthcare Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Max Healthcare Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters23.7423.7523.7523.76
        Pledge0.000.000.000.00
        FII56.9957.3360.6960.39
        DII15.3614.9611.5411.40
        Mutual Funds12.1912.3310.6210.55
        Others3.903.964.024.44
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters23,07,77,69923.74 %-0.01
        Pledge00.00 %0.00
        FII55,38,13,91856.99 %-0.34
        DII14,93,09,22815.36 %0.39
        MF11,84,50,02012.19 %-0.14
        Others3,80,11,5633.90 %-0.05

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Max Healthcare Board Meeting/AGM

      • Max Healthcare Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Aug 01, 2024Jul 24, 2024Board MeetingQuarterly Results
        May 22, 2024May 16, 2024Board MeetingAudited Results & Final Dividend
        Jan 31, 2024Jan 20, 2024Board MeetingQuarterly Results
        Nov 06, 2023Oct 27, 2023Board MeetingQuarterly Results
        Sep 27, 2023Aug 23, 2023AGM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final15%1.5Aug 23, 2024May 22, 2024
        Final10%1.0Sep 08, 2023May 16, 2023
      • No other corporate actions details are available.

      About Max Healthcare

      Max Healthcare Institute Ltd., incorporated in the year 2001, is a Small Cap company (having a market cap of Rs 84,221.07 Crore) operating in Hospitals & Allied Services sector. Max Healthcare Institute Ltd. key Products/Revenue Segments include HealthCare Services, Drugs & Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • AS

        Abhay Soi

        Chairman & Managing Director
        AB

        Anil Bhatnagar

        Non Executive Director
        NK

        Narayan K Seshadri

        Non Executive Director
        AG

        Amrita Gangotra

        Independent Woman Director
        Show More
      • Deloitte Haskins & Sells
        S R Batliboi & Co. LLP

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times